INNOVATION THAT DELIVERS Trademark

Trademark Overview

On Friday, January 28, 2022, a trademark application was filed for INNOVATION THAT DELIVERS with the United States Patent and Trademark Office. The USPTO has given the INNOVATION THAT DELIVERS trademark a serial number of 97243517. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by MABLYTICS, INC.. The INNOVATION THAT DELIVERS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields related to antibodies
innovation that delivers

General Information

Serial Number97243517
Word MarkINNOVATION THAT DELIVERS
Filing DateFriday, January 28, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields related to antibodies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMABLYTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameMABLYTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 7, 2023SOU EXTENSION 1 GRANTED
Monday, August 7, 2023SOU EXTENSION 1 FILED
Monday, August 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2022ASSIGNED TO EXAMINER
Friday, August 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 30, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 30, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 1, 2022NEW APPLICATION ENTERED

Related Keywords

delivers innovation related antibodies fields biotechnology development pharmaceutical research